Are all insulin secretagogues equal in cardiovascular toxicity?

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1348-1349, 2011-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Antiepileptic Drugs on Sleep Structure: Are All Drugs Equal?

By Bazil C.W.

CNS Drugs, Vol. 17, Iss. 10, 2003-01 ,pp. : 719-728

Adis International

Access to resources Recommend Favorite

Pertussis vaccines: are they equal?

Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Antidiabetic Drugs Present and Future: Will Improving Insulin Resistance Benefit Cardiovascular Risk in Type 2 Diabetes Mellitus?

By Campbell I.W.

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1017-1028

Adis International

Access to resources Recommend Favorite

Tocopherol: cardiovascular benefits in haemodialysis?

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Estradiol for the prevention of cardiovascular disease?

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite